A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model.
Glaucoma is a multifactorial optic neuropathy that primarily affecting retinal ganglion cells (RGC). Brimonidine is an intraocular pressure-lowering drug with reported neuroprotective properties. This study aimed to compare the neuroprotective effects of topical and intraperitoneal (IP) brimonidine...
Saved in:
Main Authors: | Ruta Maciulaitiene, Giedrius Kalesnykas, Dainius Haroldas Pauza, Ingrida Januleviciene |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0308671 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Topical Brimonidine 0.15% on Conjunctival Injection after Strabismus Surgery in Children
by: Dong Hyun Kim, et al.
Published: (2021-01-01) -
Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
by: Yuka Kasuya, et al.
Published: (2020-01-01) -
Intraoperative Local Administration of Platelet-Rich Plasma (PRP) during Neurolysis Surgery for the Treatment of Digital Nerve Crush Injury
by: Akira Ikumi, et al.
Published: (2018-01-01) -
The Effectiveness of Ebselen in Facial Nerve Crush Injury: An Experimental Study
by: Lütfü Şeneldir, et al.
Published: (2024-11-01) -
Optic nerve glioma
by: U. Masilionytė, et al.
Published: (2023-10-01)